Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Understand the dynamics of wealth building by comparing real estate and stocks. Find out which option may yield faster returns for your investments.
26,865 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Anthropic's Claude Opus 4.6 launch jolts tech stocks and Bitcoin, signaling a deeper tech-cycle adjustment rather tha...
The S&P 500 just marked its 21st seven-month streak in a century. History suggests a mix of gains and caution ahead, ...
A Kalshi insider-trading probe sparks headlines about a captivating, hypothetical scenario: a mrbeast video editor fi...
The Pitt's latest season dives into a hospital cyberattack, a scenario many experts say echoes real-world risk in hea...
Imagine a world where your phone pays you back for every scroll and tap. This article dives into Mode Mobile, a specu...
A landmark ruling would change who pays tariff costs and could lift earnings for U.S. companies. Markets react as inv...
Cathie Wood loading this often sparks questions about the viability of disruptive bets in aviation. This guide breaks...
IonQ just crossed a historic revenue milestone, signaling a turning point for pure-play quantum investing. This artic...
Claude AI’s world predictions for two World Cup matches produced a mixed bag: a precise call in USA vs Australia and ...
A sharp pullback in the IGV ETF puts a spotlight on Oracle’s ability to generate free cash flow amid AI investments. ...
Bitcoin’s wild moves test every investor, even high-profile ones. This piece dives into Dave Portnoy’s experience, th...